These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 35759443)

  • 1. Role of hepatic lipid species in the progression of nonalcoholic fatty liver disease.
    Deng KQ; Huang X; Lei F; Zhang XJ; Zhang P; She ZG; Cai J; Ji YX; Li H
    Am J Physiol Cell Physiol; 2022 Aug; 323(2):C630-C639. PubMed ID: 35759443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver lipidome signature and metabolic pathways in nonalcoholic fatty liver disease induced by a high-sugar diet.
    Oliveira DT; Chaves-Filho AB; Yoshinaga MY; Paiva NCN; Carneiro CM; Miyamoto S; Festuccia WT; Guerra-Sá R
    J Nutr Biochem; 2021 Jan; 87():108519. PubMed ID: 33017610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in paediatric nonalcoholic fatty liver disease: Role of lipidomics.
    Di Sessa A; Riccio S; Pirozzi E; Verde M; Passaro AP; Umano GR; Guarino S; Miraglia Del Giudice E; Marzuillo P
    World J Gastroenterol; 2021 Jul; 27(25):3815-3824. PubMed ID: 34321846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of Fatty Acids in Non-Alcoholic Fatty Liver Disease Progression: An Update.
    Hliwa A; Ramos-Molina B; Laski D; Mika A; Sledzinski T
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34199035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sex Dimorphism of Nonalcoholic Fatty Liver Disease (NAFLD) in
    Schiffrin M; Winkler C; Quignodon L; Naldi A; Trötzmüller M; Köfeler H; Henry H; Parini P; Desvergne B; Gilardi F
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondrial dysfunction-related lipid changes occur in nonalcoholic fatty liver disease progression.
    Peng KY; Watt MJ; Rensen S; Greve JW; Huynh K; Jayawardana KS; Meikle PJ; Meex RCR
    J Lipid Res; 2018 Oct; 59(10):1977-1986. PubMed ID: 30042157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic lipid droplets: A balancing act between energy storage and metabolic dysfunction in NAFLD.
    Mashek DG
    Mol Metab; 2021 Aug; 50():101115. PubMed ID: 33186758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update on lipid species and paediatric nonalcoholic fatty liver disease.
    Mann JP; Feldstein AE; Nobili V
    Curr Opin Clin Nutr Metab Care; 2017 Mar; 20(2):110-116. PubMed ID: 27906700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stable Isotope-Labeled Lipidomics to Unravel the Heterogeneous Development Lipotoxicity.
    Shih LM; Tang HY; Lynn KS; Huang CY; Ho HY; Cheng ML
    Molecules; 2018 Nov; 23(11):. PubMed ID: 30400243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipidomic Analysis of the Protective Effects of Shenling Baizhu San on Non-Alcoholic Fatty Liver Disease in Rats.
    Deng Y; Pan M; Nie H; Zheng C; Tang K; Zhang Y; Yang Q
    Molecules; 2019 Oct; 24(21):. PubMed ID: 31683679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent insights into hepatic lipid metabolism in non-alcoholic fatty liver disease (NAFLD).
    Musso G; Gambino R; Cassader M
    Prog Lipid Res; 2009 Jan; 48(1):1-26. PubMed ID: 18824034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired hepatic lipid metabolism and biomarkers in fatty liver disease.
    Teixeira FS; Pimentel LL; Pintado ME; Rodríguez-Alcalá LM
    Biochimie; 2023 Dec; 215():69-74. PubMed ID: 37769937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic Lipidomics Analysis Reveals the Ameliorative Effects of Highland Barley β-Glucan on Western Diet-Induced Nonalcoholic Fatty Liver Disease Mice.
    Liu H; Chen T; Xie X; Wang X; Luo Y; Xu N; Sa Z; Zhang M; Chen Z; Hu X; Li J
    J Agric Food Chem; 2021 Aug; 69(32):9287-9298. PubMed ID: 34347479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonalcoholic fatty liver disease stratification by liver lipidomics.
    Vvedenskaya O; Rose TD; Knittelfelder O; Palladini A; Wodke JAH; Schuhmann K; Ackerman JM; Wang Y; Has C; Brosch M; Thangapandi VR; Buch S; Züllig T; Hartler J; Köfeler HC; Röcken C; Coskun Ü; Klipp E; von Schoenfels W; Gross J; Schafmayer C; Hampe J; Pauling JK; Shevchenko A
    J Lipid Res; 2021; 62():100104. PubMed ID: 34384788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-invasive assessment of hepatic lipid subspecies matched with non-alcoholic fatty liver disease phenotype.
    Erickson ML; Haus JM; Malin SK; Flask CA; McCullough AJ; Kirwan JP
    Nutr Metab Cardiovasc Dis; 2019 Nov; 29(11):1197-1204. PubMed ID: 31371265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ursodeoxycholyl Lysophosphatidylethanolamide modifies aberrant lipid profiles in NAFLD.
    Pathil A; Liebisch G; Okun JG; Chamulitrat W; Schmitz G; Stremmel W
    Eur J Clin Invest; 2015 Sep; 45(9):925-31. PubMed ID: 26108973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of hepatic lipid composition in obesity-related metabolic disease.
    Willis SA; Bawden SJ; Malaikah S; Sargeant JA; Stensel DJ; Aithal GP; King JA
    Liver Int; 2021 Dec; 41(12):2819-2835. PubMed ID: 34547171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of farnesoid X receptor in hepatic steatosis in nonalcoholic fatty liver disease.
    Xi Y; Li H
    Biomed Pharmacother; 2020 Jan; 121():109609. PubMed ID: 31731192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease.
    Ipsen DH; Lykkesfeldt J; Tveden-Nyborg P
    Cell Mol Life Sci; 2018 Sep; 75(18):3313-3327. PubMed ID: 29936596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postprandial Plasma Lipidomics Reveal Specific Alteration of Hepatic-derived Diacylglycerols in Nonalcoholic Fatty Liver Disease.
    Velenosi TJ; Ben-Yakov G; Podszun MC; Hercun J; Etzion O; Yang S; Nadal C; Haynes-Williams V; Huang WA; González-Hódar L; Brychta RJ; Takahashi S; Akkaraju V; Krausz KW; Walter M; Cai H; Walter PJ; Muniyappa R; Chen KY; Gonzalez FJ; Rotman Y
    Gastroenterology; 2022 Jun; 162(7):1990-2003. PubMed ID: 35283114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.